Annexon, Inc. (ANNX)
NGS · Common · CUSIP 03589W102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ANNX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
03589W102
Market Cap
Large Cap
IPO
7/24/2020 · $17.00/share
Business: Annexon, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye.

Company Contact

CEO
Douglas Love
CFO
Jennifer Lew
Headquarters
1400 Sierra Point Parkway, Bldg C, Suite 200, Brisbane, CA 94005
Phone
650-822-5500
Investor Relations
Joyce Allaire, LifeSci Advisors · jallaire@lifesciadvisors.com
General Email
investors@annexonbio.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »